IRIS
GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.323
NA - Nord America 8.798
EU - Europa 3.438
SA - Sud America 1.012
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 165
OC - Oceania 80
Totale 27.022
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.904
US - Stati Uniti d'America 8.470
CN - Cina 1.844
IT - Italia 1.676
HK - Hong Kong 1.100
BR - Brasile 720
VN - Vietnam 451
GB - Regno Unito 406
BD - Bangladesh 379
FR - Francia 345
DE - Germania 257
NL - Olanda 165
IN - India 156
CA - Canada 152
RU - Federazione Russa 138
AR - Argentina 102
ID - Indonesia 90
AU - Australia 79
EE - Estonia 75
MX - Messico 72
IL - Israele 58
CZ - Repubblica Ceca 54
EC - Ecuador 53
TR - Turchia 51
CO - Colombia 49
FI - Finlandia 49
ZA - Sudafrica 49
UA - Ucraina 45
ES - Italia 39
JP - Giappone 38
SC - Seychelles 34
PH - Filippine 31
IQ - Iraq 28
PK - Pakistan 28
PL - Polonia 25
CL - Cile 24
MY - Malesia 24
SA - Arabia Saudita 24
IR - Iran 21
MA - Marocco 20
PY - Paraguay 19
VE - Venezuela 19
CR - Costa Rica 18
JM - Giamaica 17
BE - Belgio 16
MD - Moldavia 15
SE - Svezia 15
TN - Tunisia 15
AT - Austria 13
HN - Honduras 13
AL - Albania 12
GR - Grecia 12
LT - Lituania 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
TH - Thailandia 11
GT - Guatemala 10
PE - Perù 10
BO - Bolivia 9
CH - Svizzera 9
NI - Nicaragua 9
UZ - Uzbekistan 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
JO - Giordania 8
SV - El Salvador 8
EG - Egitto 7
TT - Trinidad e Tobago 7
CW - ???statistics.table.value.countryCode.CW??? 6
IE - Irlanda 6
KE - Kenya 6
NP - Nepal 6
UY - Uruguay 6
AM - Armenia 5
GE - Georgia 5
HU - Ungheria 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
TW - Taiwan 5
KW - Kuwait 4
LK - Sri Lanka 4
MK - Macedonia 4
PR - Porto Rico 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
ET - Etiopia 3
GA - Gabon 3
LB - Libano 3
MQ - Martinica 3
OM - Oman 3
BH - Bahrain 2
CG - Congo 2
CM - Camerun 2
CY - Cipro 2
DK - Danimarca 2
Totale 26.782
Salva come PNG Salva come JPEG
Città #
Ashburn 2.267
San Jose 1.804
Singapore 1.260
Hong Kong 1.082
Rome 874
Hefei 615
Council Bluffs 475
Dallas 423
Boardman 373
Columbus 350
Beijing 346
Lauterbourg 281
London 277
Shanghai 210
Phoenix 191
Ho Chi Minh City 150
Santa Clara 145
Amsterdam 109
Los Angeles 109
Hanoi 108
New York 106
Milan 83
Munich 75
Tallinn 69
São Paulo 63
San Francisco 51
Washington 47
Mexico City 45
Seattle 45
Frankfurt am Main 42
Brno 39
Buffalo 39
Atlanta 33
Las Vegas 33
Pune 33
Brooklyn 32
Chicago 32
Naples 32
Montreal 31
Tokyo 31
Helsinki 30
Toronto 30
Denver 28
Rio de Janeiro 27
Melbourne 26
West Jordan 26
Chennai 23
Orem 23
Bologna 22
Perth 22
Boston 19
Turin 19
Warsaw 19
Brasília 18
Johannesburg 18
Turku 18
Guayaquil 17
Jinan 17
Manchester 17
Qingdao 17
Florence 16
Palermo 16
Philadelphia 16
Quito 16
Santiago 16
Da Nang 15
Nuremberg 15
Reggio Emilia 15
Bari 14
Jakarta 14
Porto Alegre 14
Xi'an 14
Haiphong 13
Hangzhou 13
Salvador 13
Shenzhen 13
Sydney 13
Thái Bình 13
San José 12
St Louis 12
Belo Horizonte 11
Bengaluru 11
Biên Hòa 11
Dhaka 11
Hanover 11
Miami 11
North Bergen 11
Bogotá 10
Bắc Ninh 10
Charlotte 10
Delhi 10
Genoa 10
Hải Dương 10
Kuala Lumpur 10
Olomouc 10
Oxford 10
Paris 10
Queens 10
Staten Island 10
Stockholm 10
Totale 13.336
Salva come PNG Salva come JPEG
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 469
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 288
Current management and prognosis of patients with recurrent myocardial infarction 268
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 257
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 254
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 253
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 251
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 250
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 250
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 249
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 241
Simultaneous presence of Brugada and overgrowth syndromes 240
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 240
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 236
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 236
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 235
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 235
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 235
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 234
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 229
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 228
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 227
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 227
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 226
Age and heart transplantation: results from a heart failure management unit. 222
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 221
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 221
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 218
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 218
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 217
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 208
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 204
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 190
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 165
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 162
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 161
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 160
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 159
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 158
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 157
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 147
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 144
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 144
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 143
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 142
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 139
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 136
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 134
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 133
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 133
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 129
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 128
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 128
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 127
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 125
Invasive Assessment of Coronary Microvascular Function 123
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 122
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 121
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 121
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 118
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 118
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 115
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 112
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 111
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 108
The current paradigm of cardiac troponin increase among athletes 108
Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse: Prevalence, Predictors, and Association With Outcomes 106
Length and Type of Antibiotic Prophylaxis for Infection Prevention in Adults Patient in the Cardiac Surgery Intensive Care Unit: A Narrative Review 106
Athlete's ECG Made Easy: A Practical Guide to Surviving Everyday Clinical Practice 105
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 97
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 95
Edge-to-edge repair for tricuspid regurgitation: 1-year follow-up and clinical implications from the TR-Interventional Study 92
Eosinophilic Myocarditis: From Bench to Bedside 92
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 91
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study 90
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 90
The safety of transesophageal echocardiography to guide transcatheter tricuspid valve edge-to-edge repair 89
Indexing left ventricular end-systolic dimension to body size: Association with mortality in patients with degenerative mitral regurgitation 88
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 87
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 87
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 86
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 85
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis 85
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 82
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 82
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 81
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 80
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 79
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 77
The Central Role of Left Atrium in Heart Failure 76
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 76
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 76
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 75
Effects of Environmental Conditions on Athlete's Cardiovascular System 75
Evaluation of postural disorders in patients pre and post heart transplant. 74
Factors influencing post-surgical survival in degenerative mitral regurgitation 74
Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation 73
Role of polypill in cardiovascular prevention and treatment 71
Management of asymptomatic mitral regurgitation. 71
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 70
Totale 15.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 0 0 0 0 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/202610.963 822 376 849 1.295 435 674 2.595 931 901 963 654 468
2026/20273.790 279 993 924 1.200 394 0 0 0 0 0 0 0
Totale 27.022